FI913100A0 - Farmaceutiska preparat. - Google Patents

Farmaceutiska preparat.

Info

Publication number
FI913100A0
FI913100A0 FI913100A FI913100A FI913100A0 FI 913100 A0 FI913100 A0 FI 913100A0 FI 913100 A FI913100 A FI 913100A FI 913100 A FI913100 A FI 913100A FI 913100 A0 FI913100 A0 FI 913100A0
Authority
FI
Finland
Prior art keywords
pharmaceutical preparation
preparations
androgen
liposomes
preferably used
Prior art date
Application number
FI913100A
Other languages
English (en)
Inventor
Georg Roessling
Andreas Sachse
Jutta Riedl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI913100A0 publication Critical patent/FI913100A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI913100A 1989-10-27 1991-06-25 Farmaceutiska preparat. FI913100A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3936328A DE3936328A1 (de) 1989-10-27 1989-10-27 Pharmazeutische praeparate
PCT/DE1990/000776 WO1991006284A1 (de) 1989-10-27 1990-10-10 Pharmazeutische präparate

Publications (1)

Publication Number Publication Date
FI913100A0 true FI913100A0 (fi) 1991-06-25

Family

ID=6392630

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913100A FI913100A0 (fi) 1989-10-27 1991-06-25 Farmaceutiska preparat.

Country Status (15)

Country Link
US (1) US5723146A (fi)
EP (1) EP0451237B1 (fi)
JP (1) JP3011762B2 (fi)
AT (1) ATE103804T1 (fi)
AU (1) AU6553790A (fi)
CA (1) CA2028629C (fi)
DE (2) DE3936328A1 (fi)
DK (1) DK0451237T3 (fi)
FI (1) FI913100A0 (fi)
GR (1) GR900100772A (fi)
HU (1) HU215127B (fi)
IE (1) IE903859A1 (fi)
NO (1) NO912435L (fi)
PT (1) PT95697B (fi)
WO (1) WO1991006284A1 (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733776B1 (en) * 1992-04-02 2004-05-11 Anticancer, Inc. Method for promoting hair growth
US7556825B2 (en) * 1993-04-02 2009-07-07 Anticancer, Inc. Method for promoting hair growth
US6844326B2 (en) * 1995-06-07 2005-01-18 Anticancer, Inc. Treatment of alopecia
DE19916384A1 (de) * 1999-03-31 2000-10-05 Schering Ag Cyproteronacetat, Chlormadinonacetat oder 17alpha-Propylmesterolon enthaltende, bioerosive Mikropartikeln, Verfahren zu deren Herstellung, therapeutische Verwendung dieser in topischen Arzneiformen
JP3466516B2 (ja) 1999-09-07 2003-11-10 科学技術振興事業団 安定保存可能な酸素輸液剤
EP1316317A1 (fr) * 2001-11-30 2003-06-04 University of Liege Associations hydrosolubles à base de cyprotérone et/ou d'un ester de celle-ci, leurs préparations et leurs utilisations
US20030219465A1 (en) * 2002-05-23 2003-11-27 Suresh Kumar Gidwani Composition for delivery of dithranol
US20060165744A1 (en) * 2003-05-22 2006-07-27 Neopharm, Inc Combination liposomal formulations
US20050095283A1 (en) * 2003-09-16 2005-05-05 Aphios Corporation Compositions and methods for topically treating diseases
BRPI0514898A (pt) * 2004-09-03 2008-06-24 Piedmont Pharmaceuticals Llc métodos para tratamento e prevenção transmembrana da otite média
ZA200803367B (en) * 2005-09-26 2009-09-30 Piedmont Pharmaceuticals Llc Methods for treatment and prevention of otitis media using chemical penetration enhancers to facilitate transmembrane drug delivery into the middle ear
EA200800950A1 (ru) * 2005-09-26 2008-08-29 ПЬЕДМОН ФАРМАСЬЮТИКАЛЗ ЭлЭлСи Способы лечения и профилактики среднего отита с применением неионных поверхностно-активных веществ для облегчения трансмембранного введения лекарственного средства в среднее ухо
DE102006062120A1 (de) 2006-12-22 2008-06-26 Grünenthal GmbH Pharmazeutische Zusammensetzung zur Aknebehandlung
JP5128592B2 (ja) * 2007-05-29 2013-01-23 ポーラ化成工業株式会社 皮膚外用剤に有用なベシクル及び該ベシクルを含有する皮膚外用剤
US8288342B2 (en) * 2008-10-10 2012-10-16 Teva Women's Health, Inc. Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate
ITMI20110644A1 (it) * 2011-04-14 2012-10-15 Giuliani Spa Sistema per il rilascio prolungato di agenti cosmetici

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3728364A (en) * 1971-07-27 1973-04-17 Syntex Corp Preparation of 17alpha-propadienyl steroids
GB1570524A (en) * 1976-03-11 1980-07-02 Unilever Ltd Cosmetic
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
US4396615A (en) * 1981-06-24 1983-08-02 Duke University Method of treating androgen-related disorders
GB2112730B (en) * 1981-09-30 1985-12-18 Nat Res Dev Encapsulated particles
DE3416978A1 (de) * 1983-05-12 1984-12-06 Stauffer Chemical Co., Westport, Conn. Durch liposom vermittelte transformation eukaryotischer zellen
EP0240630A3 (en) * 1986-04-10 1989-01-25 University Of Miami Treatment of skin of over androgenicity using compositions containing pregnenolone
AU4805085A (en) * 1984-09-05 1986-03-24 Schering Aktiengesellschaft Mittel zur behandlung von androgenisierungserscheinungen und verwendung von antiandrogenen zur herstellung des mittels
IT1199625B (it) * 1985-01-08 1988-12-30 Finchimica Srl Uso terapeutico del ciproterone acetato
FR2619505B1 (fr) * 1987-08-20 1990-08-31 Dior Christian Parfums Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant
DE3738620A1 (de) * 1987-11-13 1989-05-24 Luderschmidt Christoph Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs

Also Published As

Publication number Publication date
JP3011762B2 (ja) 2000-02-21
DE3936328A1 (de) 1991-05-02
CA2028629C (en) 2000-12-19
DK0451237T3 (da) 1994-07-18
HUT57590A (en) 1991-12-30
ATE103804T1 (de) 1994-04-15
NO912435D0 (no) 1991-06-21
JPH04503676A (ja) 1992-07-02
IE903859A1 (en) 1991-05-08
EP0451237B1 (de) 1994-04-06
HU215127B (hu) 1998-09-28
HU907959D0 (en) 1991-11-28
US5723146A (en) 1998-03-03
EP0451237A1 (de) 1991-10-16
DE59005281D1 (de) 1994-05-11
PT95697B (pt) 1997-09-30
PT95697A (pt) 1991-09-13
WO1991006284A1 (de) 1991-05-16
CA2028629A1 (en) 1991-04-28
AU6553790A (en) 1991-05-02
GR900100772A (el) 1992-03-20
NO912435L (no) 1991-06-21

Similar Documents

Publication Publication Date Title
FI913100A0 (fi) Farmaceutiska preparat.
EE9900075A (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
DK634787D0 (da) Topiske farmaceutiske praeparater til behandling af acne
NO884154D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive preparater.
NO921875L (no) Metallpeptidpreparater og fremgangsmaater for aa stimulere haarvekst
NO922005D0 (no) Farmasoeytiske preparater
KR880005921A (ko) 의약용 소입자 에어로졸 리포좀 및 의약용 리포좀-약제 조합물
NO910340D0 (no) Topiske preparater for behandling av menneskenegler.
DK229387A (da) Retinoesyreestere, deres fremstilling og farmaceutiske og kosmetiske praeparater deraf
DK296690D0 (da) Topisk, kosmetisk og farmaceutisk praeparat
DE69013557D1 (de) An Liposome gekuppelte bioaktive Verbindungen und ihre Verwendung in pharmazeutischen Zubereitungen.
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
DK298389D0 (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament
IT1134458B (it) Derivato della n-acetil-cisteina ad attivita' terapeutica,procedimento per la sua preparazione e relative composizioni farmaceutiche
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
ATE142503T1 (de) Arzneimittelzubereitung bei der behandlung von tonsillitis
DK453688A (da) Farmaceutiske praeparater til topisk anvendelse
FR2549835B1 (fr) Acides peneme-carboxyliques, leur preparation et leur utilisation therapeutique, notamment en tant qu'agents antibacteriens
FR2578745B1 (fr) Preparations pharmaceutiques fluidifiant le sang
ES2010963A4 (es) Derivados de n - cicloalkilaminoetilbenzamida, su sintesis y preparacion farmaceutica
FI940717A0 (fi) Streptogramiinien puhdistetut muodot, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
IT8321398A1 (it) Preparazioni farmaceutiche per trattamento topico della cataratta
ITRM940453A1 (it) "uso della proteina p1lsa per la preparazione di un medicamento da utilizzarsi nella terapia di patologie indotte da danni cellulari da
FR2587217B1 (fr) Preparations pharmaceutiques immunomodulantes
ITMI922216A1 (it) Nitrobenzoilalanine, procedimento per la loro preparazione, loro uso come agenti terapeutici e composizioni farmaceutiche che le contengono

Legal Events

Date Code Title Description
FD Application lapsed